Tatva Chintan Pharma Chem Limited IPO Details

We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. 

We continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products, we serve customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from our customers in India, we also export our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. We believe that the knowledge and experience of our management team provides us with a significant competitive advantage as we seek to grow our business.

Tatva Chintan Pharma Chem Limited IPO Details
Issue Open	16-07-2021
Issue Close	20-07-2021
Allotment Date	26-07-2021
Unblocked Amount	27-07-2021
Listing Date	28-07-2021
Issue Size	43,35,260 Total Equity Share - Fresh Issue Equity Share - OFS Equity Share
Issue Size	₹ 500 Cr ₹ 225 Cr Fresh ₹ 275 Cr OFS
IPO Price Band	₹ 1073-1083
Minimum Share Bid	13
Minimum Investment Amount [₹]	₹ 14,079
Face Value	₹ 10
Qualified Institutional Buyer [QIB]	- %
High Networth Individual [HNI]	- %
Retail Individual Investor [RII]	- %
Listing On	BSE & NSE

Tatva Chintan Pharma Chem Limited IPO Grey Market Premium
Date	Offer Price	Premium	Kostak	Subject to Sauda	Listing Gain	Rating
19-07-2021	1083	740	450	8500	9500	Apply
20-07-2021	1083	760	450	8500	9500	Apply
21-07-2021	1083	810	550	9500	10500	Apply
-	-	-	-	-	-	-

Tatva Chintan Pharma Chem Limited IPO Financial details [in Rs, Cr]
Financial Year	Total Asset	Total Revenue	Total Expenses	Profit After Tax
FY-2018	143.716	137.288	118.254	12.28
FY-2019	187.508	206.801	180.157	20.54
FY-2020	248.938	264.622	217.025	37.78
31-12-2021	275.985	195.034	158.577	31.14

Tatva Chintan Pharma Chem Limited IPO Valuation Details
Earnings Per Share [EPS]	₹ 18.81
Price/Earnings [P/E] Ratio	59.29
Return on Net Worth [RoNW]	32.11 %
Net Asset Value [NAV]	₹ 72.05 Per Share

Tatva Chintan Pharma Chem Limited IPO Subscription Details
As on Date	QIB	NII	RII	Total
Shared Offered	9,31,966	6,98,975	16,30,941	32,61,882
Day-1 [16-07-2021]	4,68,143 [0.5]	7,93,975 [1.14]	16,30,941 [8.24]	1,47,08,655 [4.51]
Day-2 [19-07-2021]	18,31,375 [1.97]	85,31,744 [12.21]	3,87,21,046 [23.74]	4,90,84,165 [15.05]
Day-3 [20-07-2021]	17,26,28,313 [185.23]	35,80,28,073 [512.22]	5,76,52,010 [35.35]	58,83,08,396 [180.36]

Tatva Chintan Pharma Chem Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here

Tatva Chintan Pharma Chem Limited IPO Allotment Status
Check Allotment Status :- Click Here

Live Subscription for Tatva Chintan Pharma Chem Limited IPO
Check Live Subscription in BSE:- Click Here to View Check Live Subscription in NSE:- Click Here to View

Download Tatva Chintan Pharma Chem Limited IPO DRHP & RHP
Download DRHP:- Click Here to Download Download RHP:- Click Here to Download

Tatva Chintan Pharma Chem Limited IPO Contact Details
Tatva Chintan Pharma Chem Limited Plot No. 353, Makarpura GIDC, Vadodara, Gujarat – 390 010, India, Contact Person: Apurva Dubey, Company Secretary and Compliance Officer; Telephone: + 91 75748 48533 / +91 75748 48534 E-mail: cs@tatvachintan.com Website: www.tatvachintan.com Corporate Identity Number: U24232GJ1996PLC029894

Registrar of Tatva Chintan Pharma Chem Limited IPO
Link Intime India Private Limited C-101, 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai, Maharashtra - 400 083 India, Telephone: +91 (22) 4918 6200 E-mail: tatva.ipo@linkintime.co.in Website: www.linkintime.co.in Investor grievance e-mail: tatva.ipo@linkintime.co.in Contact person: Shanti Gopalkrishnan SEBI registration number: INR000004058

Lead Managers of Tatva Chintan Pharma Chem Limited IPO

ICICI Securities Limited ICICI Centre H.T. Parekh Marg Churchgate, Mumbai Maharashtra – 400 020, India Telephone: +91 22 2288 2460 E-mail: tatvachintan.ipo@icicisecurities.com Investor grievance e-mail: customercare@icicisecurities.com Website: www.icicisecurities.com Contact person: Vaibhav Saboo / Anurag Bya JM Financial Limited 7th Floor, Cnergy Appasaheb Marathe Marg Prabhadevi, Mumbai 400 025 Maharashtra, India Telephone: + 91 22 6630 3030 E-mail: tatvachintan.ipo@jmfl.com Investor grievance e-mail: grievance.ibd@jmfl.com Website: www.jmfl.com Contact person: Prachee Dhuri SEBI registration number: INM000010361

Disclaimer:-

•       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO. •       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk •        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO. •       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.